ArticleFrontiers in oncology2024

Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report.

Bo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.